| Dec'17 | Dec'16 | Dec'15 | ||||
|---|---|---|---|---|---|---|
REVENUE | ||||||
Reducer | ||||||
1,128 | 1,004 | 526 | ||||
Product sales | ||||||
- | - | 353 | ||||
Contract manufacturing | ||||||
949 | 3,746 | 3,236 | ||||
Consulting services | ||||||
3,311 | 4,761 | 5,812 | ||||
Total Revenue | ||||||
5,389 | 9,512 | 9,929 | ||||
COST OF GOODS SOLD | ||||||
3,477 | 7,091 | 6,938 | ||||
GROSS PROFIT | ||||||
1,911 | 2,421 | 2,991 | ||||
EXPENSES | ||||||
Selling expenses | ||||||
886 | 696 | 655 | ||||
General and administrative expenses | ||||||
15,684 | 19,182 | 13,913 | ||||
Product development and clinical trials expenses | ||||||
17,489 | 19,364 | 17,181 | ||||
Total Expenses | ||||||
34,060 | 39,243 | 31,750 | ||||
OPERATING LOSS | ||||||
-32,148 | -36,822 | -28,758 | ||||
OTHER INCOME/(EXPENSE) | ||||||
Interest income | ||||||
355 | 177 | 577 | ||||
Interest expense | ||||||
- | - | 2 | ||||
Damages provision | ||||||
738 | 111,781 | - | ||||
Gain on sale of assets | ||||||
- | 65,095 | - | ||||
Gain/(loss) on foreign exchange | ||||||
2,726 | -273 | 1,620 | ||||
Unrealized gain on derivative liability and convertible note | ||||||
10,732 | - | - | ||||
Amortization of deferred loss | ||||||
3,351 | - | - | ||||
Foreign exchange loss on damages provision | ||||||
- | 2,690 | - | ||||
Total Other Income/(Expense) | ||||||
9,724 | -49,471 | 2,195 | ||||
LOSS BEFORE TAX | ||||||
-22,424 | -86,294 | -26,563 | ||||
Tax expense | ||||||
484 | 200 | 167 | ||||
LOSS FOR THE YEAR | ||||||
-22,908 | -86,494 | -26,730 | ||||
OTHER COMPREHENSIVE (LOSS)/GAIN FOR THE YEAR | ||||||
Items that will be reclassified subsequently to profit or loss | ||||||
Exchange difference on translation for other than damages provision | ||||||
-1,950 | 1,406 | -8,386 | ||||
Exchange difference on translation for damages provision | ||||||
- | 2,690 | - | ||||
TOTAL OTHER COMPREHENSIVE (LOSS)/GAIN FOR THE YEAR | ||||||
-1,950 | 4,096 | -8,386 | ||||
LOSS AND OTHER COMPREHENSIVE LOSS FOR THE YEAR | ||||||
-24,859 | -82,397 | -35,116 | ||||
LOSS PER SHARE | ||||||
Basic and diluted loss per share | ||||||
-0.28 | -1.28 | -0.41 | ||||